Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/22/2003CN1450906A Methods and compositions for peptide synthesis
10/22/2003CN1450239A Emergency door opening system
10/22/2003CN1450169A Separation purification method for preparing sex-gene recombination spider dragline silk protein
10/22/2003CN1450085A Human red blood cell source depressor factor and use thereof
10/22/2003CN1450084A Novel process for preparing recombinaant CHO cell hepatitis B vaccine
10/22/2003CN1449832A Horse SARS-resisting serum
10/22/2003CN1125181C Vector for expression of N-terminally extended proteins in yeast cell
10/22/2003CN1125180C Promoters
10/22/2003CN1125174C Recombinant phages
10/22/2003CN1125083C Monoclonal antibody active against CD44V6
10/22/2003CN1125082C Human chemokine beta-8 chemokine beta-1 and macrophage inflammatory protein-4
10/22/2003CN1125081C Recombined natural and new-type human insulin and its preparation
10/22/2003CN1125078C Active peptide
10/21/2003US6635811 Pre-harvest sprouting
10/21/2003US6635806 Methods and compositions for expression of transgenes in plants
10/21/2003US6635751 Nucleic acid encoding factor capable of efficiently regulating expression of endoplasmic reticulum chaperone gene, or complementary strand nucleic acid
10/21/2003US6635750 B7-H2 nucleic acids, members of the B7 family
10/21/2003US6635749 Auxotrophic attenuated strain of Listeria with a mutation in genes whose protein product is essential for growth used to elicit a t-cell immune response to an antigen
10/21/2003US6635748 Protein for use as antitumor agent; for use as antimetastsis agent
10/21/2003US6635746 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and methods of preparation thereof
10/21/2003US6635744 Substantially pure fibroblast growth factor homologous factor-4 polypeptide having specified amino acid sequence; diagnosis and treatment of neurodegenerative and neoplastic disorders
10/21/2003US6635743 Isolated antibody or portion that binds to protein selected from those having specified amino acid sequences or fragments; control apoptosis for treatment of autoimmune disease, graft versus host disease, rheumatoid arthritis and lymphadenopathy
10/21/2003US6635742 Antibodies specific for semaphorin-like polypeptides
10/21/2003US6635741 G-protein coupled receptor BCA-GPCR-3
10/21/2003US6635740 Ligand/lytic peptide compositions and methods of use
10/21/2003US6635627 Anti-cancer products for treating cystic fibrosis
10/21/2003US6635624 Plasmid of partly bacterial origin; antibiotic resistance
10/21/2003US6635623 Early detection of cancer, metastatic cancer and/or arteriosclerosis
10/21/2003US6635619 Amino acid sequence 88, 96, 97, 98, 99 or 100; increasing serum and tissue levels of active component
10/21/2003US6635616 Laminin 15
10/21/2003US6635483 Antisense polynucleotide targeted to a nucleic acid encoding the gene, thereby suppressing its expression; cDNA encapsulated in liposome; use as antitumor, anticarcinogenic or antiapoptotic; Alzheimer's disease
10/21/2003US6635482 Produced by hybridoma; cytokines; useful in diagnosis, prevention and treatment of immune system-related disorders
10/21/2003US6635481 Isolated polynucleotide
10/21/2003US6635480 Of given amino acid sequence; use in detecting and treating cell proliferation and immunological disorders by modulating its activity
10/21/2003US6635479 Hypothalamus-specific polypeptides
10/21/2003US6635478 Transfecting mammalian cell with a construct for stable expression of a gene product and a second construct comprising a antibiotic resistance gene; use in drug discovery
10/21/2003US6635477 Comprising a open reading frame; use in diagnosis, treatment and prevention
10/21/2003US6635475 DNA sequence comprising a gene promoter; expression vectors; use in screening assays to identify new antibiotics
10/21/2003US6635474 Recombinant vector plasmids for producing proteins which maintain their normal activity; useful for scale-up production, isolating and purifying with ease and safety; Human granulocyte colony stimulating factor
10/21/2003US6635473 Isolated nucleic acid encoding a fibrinogen-binding protein; useful in prevention, diagnosis and treatment of infections; can be administered to wounds or for coating prosthetics to inhibit binding of the bacteria
10/21/2003US6635472 Polynucleotide constructs which can replicate episomally in vertebrate cells without integration into the chromosomal DNA of the host; reverse transcription; use in gene transfer, gene therapy and vaccines
10/21/2003US6635468 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/21/2003US6635466 Adenovirus serotype 30 (Ad30)
10/21/2003US6635459 Capable of remaining hybridized; use to increase production of lignans in plants which confer disease resistance and are used as anticancer agents and viricides
10/21/2003US6635450 Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agents
10/21/2003US6635449 Exonuclease-mediated nucleic acid reassembly in directed evolution
10/21/2003US6635448 Culture product; using promoters; accumulation proteins
10/21/2003US6635447 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
10/21/2003US6635446 Encoded by isolated nucleic acid; given amino acid sequence; Wiskott-Aldrich Syndrome (WAS); use in diagnosing and treating conditions in which there is a DNA deficiency or mutation
10/21/2003US6635445 Isolated DNA; given amino acid sequence; useful for diagnosis and management of ovarian diseases
10/21/2003US6635443 Isolated nucleic acid; given amino acid sequence; use in diagnosing and treating immune system-related disorders
10/21/2003US6635442 Encoded by isolated DNA molecule; given amino acid sequence; useful for studying effects of chemical agents on coupled adenylate cyclase and hormone-sensitive lipases; use in controlling obesity, diabetes and hyperlipidemia
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635429 Incubating a cell containing sequence linked to a DNA response element with an agent to determine its capability of transactivating the sequence; retinoic acid, thyroid, retinoid X
10/21/2003US6635421 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
10/21/2003US6635258 Herpes simplex virus VP22 vaccines and methods of use
10/21/2003US6635257 Oligomeric particle having diameter of 1 to 100 nanometer and consisting of hepatitis C virus envelope proteins, or parts thereof, in which at least one cysteine is alkylated
10/21/2003US6635256 Administering multiple domain glycoprotein hormones containing alpha subunit covalently linked to beta subunit to form single chain hormone and additional beta subunit noncovalently linked to tethered alpha subunit of single chain hormone
10/21/2003US6635255 CASB414:antigen overexpressed in several tumors
10/21/2003US6635251 Eotaxin-specific antibodies
10/21/2003US6635244 Adenovirus E1B-55K single amino acid mutants and methods of use
10/21/2003CA2197000C Surface-modifying copolymers having cell adhesion properties
10/21/2003CA2182289C Immuno-stimulatory monoclonal antibodies
10/21/2003CA2138161C Glucagon-like peptide and insulinotropin derivatives
10/21/2003CA2115049C Dna sequences encoding gelonin polypeptide
10/21/2003CA2106962C Polypeptides from mycobacterium paratuberculosis
10/21/2003CA2072649C Methods and materials for expression of human plasminogen variant
10/21/2003CA2066940C Canine coronavirus subunit vaccine
10/21/2003CA2053924C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
10/21/2003CA2017166C Metalloproteinase inhibitor
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085375A2 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003WO2003085134A2 Methods of diagnosing and treating colorectal cancer
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085121A2 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
10/16/2003WO2003085117A1 Viral vectors comprising a nucleic sequence derived from murine leukemia viruses for gene transfer in cells
10/16/2003WO2003085114A1 Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
10/16/2003WO2003085111A1 Novel promoters
10/16/2003WO2003085103A2 Purified polypeptides involved in nucleotide hydrolysis
10/16/2003WO2003085102A1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
10/16/2003WO2003085098A2 Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti
10/16/2003WO2003085096A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2003085095A2 Novel expressed genes
10/16/2003WO2003085088A2 Pkhd1, the polycystic kidney and hepatic disease 1 gene
10/16/2003WO2003085087A2 Modified cea nucleic acid and expression vectors
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003085085A2 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
10/16/2003WO2003085084A2 Hepatitis c virus sub-genomic replicons
10/16/2003WO2003085081A2 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer
10/16/2003WO2003084995A2 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof
10/16/2003WO2003084994A2 Use of biological photoreceptors as directly light-activated ion channels
10/16/2003WO2003084993A1 Novel antagonists of mcp proteins
10/16/2003WO2003084991A1 Atopic dermatitis-inducing proteins
10/16/2003WO2003084990A1 Bage genes, proteins coded by the same, and their uses for the treatment or the diagnosis of melanomas
10/16/2003WO2003084989A2 La1 - the genome of a lactobacillus strain
10/16/2003WO2003084988A2 Cd4+ t-lymphocyte-specific hepatitis c virus epitopes
10/16/2003WO2003084987A2 Polypeptides from bacteria and uses thereof
10/16/2003WO2003084986A2 Novel purified polypeptides involved in cellular metabolism
10/16/2003WO2003084985A1 Peptide chemically modified with polyethylene glycol
10/16/2003WO2003084983A1 Process for producing modified peptide
1 ... 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 ... 2916